From Microbiome to Inflammation: The Key Drivers of Cervical Cancer
- PMID: 34867901
- PMCID: PMC8634716
- DOI: 10.3389/fmicb.2021.767931
From Microbiome to Inflammation: The Key Drivers of Cervical Cancer
Abstract
Cervical cancer is the third leading cause of cancer-related death worldwide. Microbes and hosts form a mutually beneficial symbiosis relationship, and various parts of the host body are microbial habitats. Microbes can trigger inflammation in certain parts of the host body, contributing to cervical cancer development. This article reviews the relationship between cervicovaginal microbes, inflammation and cervical cancer, and discusses the effect of some key cervical microbes on cervical cancer. Finally, probiotic therapy and immunotherapy are summarized.
Keywords: cervical cancer; immunotherapy; inflammation; microbiome; probiotic.
Copyright © 2021 Zhou, Long, Cheng, Luo, Wen and Gao.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Alvarez-Olmos M. I., Barousse M. M., Rajan L., Van Der Pol B. J., Fortenberry D., Orr D., et al. (2004). Vaginal lactobacilli in adolescents: presence and relationship to local and systemic immunity, and to bacterial vaginosis. Sex Transm. Dis. 31 393–400. 10.1097/01.olq.0000130454.83883.e9 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
